Dextroamphetamine modulates the response of the human amygdala

Neuropsychopharmacology

Volumn 27, Issue 6, 2002, Pages 1036-1040

  Hariri, Ahmad R ^a   Mattay, Venkata S ^a   Tessitore, Alessandro ^a   Fera, Francesco ^a   Smith, William G ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amphetamine; Amygdala; Anxiety; Dopamine; Fear; Monoamines

Indexed keywords

DEXAMPHETAMINE; DOPAMINE;

ADULT; AMYGDALOID NUCLEUS; ANGER; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMOTION; FACIAL EXPRESSION; FEAR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION; PRIORITY JOURNAL; STIMULUS RESPONSE;

ADULT; AMYGDALA; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0036899894     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00373-1     Document Type: Article

References (26)

1. Angrist B.M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry. 2:1970;95-107.
2. Damasio A.R. Descartes' Error. 1994;Grosset/Putnam, New York.
3. Davis M., Whalen P.J. The amygdala. vigilance and emotion Mol Psychiatry. 6:2001;13-34.
4. Ellinwood E.H. Jr., Sudilovsky A., Nelson L.M. Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry. 130:1973;1088-1093.
5. Goldstein L.E., Rasmusson A.M., Bunney B.S., Roth R.H. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci. 16:1996;4787-4798.
6. Guarraci F.A., Frohardt R.J., Kapp B.S. Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res. 827:1999;28-40.
7. Hall R.C., Popkin M.K., Beresford T.P., Hall A.K. Amphetamine psychosis. clinical presentations and differential diagnosis Psychiatr Med. 6:1988;73-79.
8. Hariri A.R., Bookheimer S.Y., Mazziotta J.C. Modulating emotional responses. effects of a neocortical network on the limbic system Neuroreport. 11:2000;43-48.
9. Harmer C.J., Hitchcott P.K., Morutto S.L., Phillips G.D. Repeated d-amphetamine enhances stimulated mesoamygdaloid dopamine transmission. Psychopharmacology (Berl). 132:1997;247-254.
10. Harmer C.J., Phillips G.D. Enhanced conditioned inhibition following repeated pretreatment with d-amphetamine. Psychopharmacology (Berl). 142:1999;120-131. a.
11. Harmer C.J., Phillips G.D. Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus. facilitation by prior repeated D-amphetamine Neuroscience. 90:1999;119-130. b.
12. Haxby J.V., Hoffman E.A., Gobbini M.I. Human neural systems for face recognition and social communication. Biol Psychiatry. 51:2002;59-67.
13. Inglis F.M., Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem. 72:1999;1088-1094.
14. Kanwisher N., McDermott J., Chun M.M. The fusiform face area. a module in human extrastriate cortex specialized for face perception J Neurosci. 17:1997;4302-4311.
15. LaBar K.S., Gitelman D.R., Mesulam M.M., Parrish T.B. Impact of signal-to-noise on functional MRI of the human amygdala. Neuroreport. 12:2001;3461-3464.
16. LeDoux J. The Emotional Brain. 1997;Touchstone, New York.
17. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B., Weinberger D.R. Dextroamphetamine enhances "neural network-specific" physiological signals. a positron-emission tomography rCBF study J Neurosci. 16:1996;4816-4822.
18. Nader K., LeDoux J.E. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci. 113:1999;891-901.
19. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 25:1997;192-216.
20. Rosenkranz J.A., Grace A.A. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci. 19:1999;11027-11039.
21. Rosenkranz J.A., Grace A.A. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci. 21:2001;4090-4103.
22. Rosenkranz J.A., Grace A.A. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci. 22:2002;324-337.
23. Thomas K.M., Drevets W.C., Whalen P.J., Eccard C.H., Dahl R.E., Ryan N.D., Casey B.J. Amygdala response to facial expressions in children and adults. Biol Psychiatry. 49:2001;309-316.
24. Willick M.L., Kokkinidis L. Cocaine enhances the expression of fear-potentiated startle. evaluation of state-dependent extinction and the shock-sensitization of acoustic startle Behav Neurosci. 109:1995;929-938.
25. Worsley K.J., Marrett P., Neelin A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp. 4:1996;58-73.
26. Zhang J., Xu M. Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems. J Addict Dis. 20:2001;7-18.